Mohammadreza Pakyari, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hamartoma Syndrome, Multiple | 1 | 2023 | 111 | 0.870 |
Why?
|
| Fibroma | 1 | 2023 | 212 | 0.820 |
Why?
|
| Skin Transplantation | 2 | 2016 | 1074 | 0.450 |
Why?
|
| Graft Survival | 3 | 2016 | 3737 | 0.390 |
Why?
|
| Immune Tolerance | 2 | 2016 | 2258 | 0.370 |
Why?
|
| Fibroblasts | 5 | 2018 | 4161 | 0.350 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2018 | 109 | 0.290 |
Why?
|
| Wound Healing | 2 | 2018 | 2785 | 0.270 |
Why?
|
| Bandages | 2 | 2016 | 266 | 0.240 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 5686 | 0.240 |
Why?
|
| Graft Rejection | 1 | 2016 | 4397 | 0.220 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2023 | 188 | 0.220 |
Why?
|
| Detergents | 1 | 2018 | 230 | 0.150 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2023 | 1142 | 0.150 |
Why?
|
| Kynurenic Acid | 1 | 2016 | 46 | 0.140 |
Why?
|
| Dermatitis | 1 | 2018 | 197 | 0.140 |
Why?
|
| Nanofibers | 1 | 2016 | 66 | 0.140 |
Why?
|
| Skin | 3 | 2018 | 4364 | 0.130 |
Why?
|
| Alopecia Areata | 1 | 2017 | 107 | 0.130 |
Why?
|
| Polymethyl Methacrylate | 1 | 2016 | 145 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 3 | 2018 | 6386 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 2214 | 0.100 |
Why?
|
| Mice, Inbred C3H | 3 | 2017 | 964 | 0.100 |
Why?
|
| Wound Infection | 1 | 2013 | 242 | 0.090 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2013 | 250 | 0.090 |
Why?
|
| Debridement | 1 | 2013 | 492 | 0.090 |
Why?
|
| Psoriasis | 1 | 2018 | 898 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 731 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 4253 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2016 | 2725 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 21827 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2017 | 1341 | 0.050 |
Why?
|
| Burns | 1 | 2013 | 1815 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 18029 | 0.050 |
Why?
|
| Mutation | 1 | 2023 | 29786 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 19905 | 0.040 |
Why?
|
| Animals | 7 | 2018 | 168757 | 0.040 |
Why?
|
| Mice | 4 | 2018 | 81183 | 0.040 |
Why?
|
| Interleukin-23 | 1 | 2018 | 193 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2016 | 425 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2017 | 277 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2017 | 5524 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2016 | 387 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2018 | 624 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2016 | 407 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2018 | 899 | 0.030 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2016 | 745 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2017 | 19229 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1741 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2016 | 1116 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2016 | 1284 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2013 | 767 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 4217 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2023 | 4445 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2016 | 4776 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2018 | 5974 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2023 | 9274 | 0.020 |
Why?
|
| Cell Movement | 1 | 2018 | 5217 | 0.020 |
Why?
|
| Humans | 4 | 2023 | 744343 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11366 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 4479 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 2988 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2016 | 6256 | 0.010 |
Why?
|
| Cytokines | 1 | 2016 | 7322 | 0.010 |
Why?
|
| Female | 5 | 2018 | 380194 | 0.010 |
Why?
|
| Male | 3 | 2016 | 350118 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 53288 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 56430 | 0.000 |
Why?
|
| Adult | 1 | 2013 | 214055 | 0.000 |
Why?
|